Evidence map›Paper›PMID 40694730›Full record

ArticleNeurology(R) neuroimmunology & neuroinflammation2025

KFLC to Total CSF Protein Ratio Is an Alternative to KFLC Index to Diagnose Multiple Sclerosis: A Retrospective Study of 814 Cases.

Estelle Moschetti, Mélany Venet, Lise Thibaudin, Amelie Moreau, Philippe Gonzalo, Jean-Philippe Camdessanche, Yannick Tholance

Abstract read
In one paragraph

Article in Neurology(R) neuroimmunology & neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Estelle MoschettiDepartment of Biochemistry, University Hospital of Saint-Etienne, France.ORCID 0009-0003-1122-5774
Mélany VenetDepartment of Neurology, University Hospital of Saint-Etienne, France; and.
Lise ThibaudinDepartment of Biochemistry, University Hospital of Saint-Etienne, France.
Amelie MoreauDepartment of Biochemistry, University Hospital of Saint-Etienne, France.
Philippe GonzaloDepartment of Biochemistry, University Hospital of Saint-Etienne, France.
Jean-Philippe CamdessancheDepartment of Neurology, University Hospital of Saint-Etienne, France; and.ORCID 0000-0002-5282-6707
Yannick TholanceDepartment of Biochemistry, University Hospital of Saint-Etienne, France.ORCID 0000-0002-1826-3031

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesBiological analyses are crucial for diagnosing multiple sclerosis (MS), notably detection of oligoclonal bands (OCBs) of immunoglobulin G in CSF. Kappa free light chain (KFLC) quantification in serum and CSF has recently been proposed as an additional test. In a rational medicoeconomic approach, identifying algorithms or biomarkers is important. The objective of this study was, therefore, to evaluate the correlation between CSF kappa free light chain (KFLC

methodsKFLC measurements were performed prospectively with each OCB analysis, and the data were interpreted retrospectively. A total of 814 clinical cases were included: 153 with MS or clinically isolated syndrome (CIS), 181 with other inflammatory neurologic diseases, and 480 with noninflammatory neurologic diseases. Performances of KFLC

resultsKFLC DISCUSSION: To conclude, KFLC CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that the KFLC

Indexed as

Immunoglobulin kappa-ChainsMultiple SclerosisOligoclonal BandsAdultAgedBiomarkersFemaleHumansMaleMiddle AgedRetrospective StudiesSensitivity and SpecificityYoung AdultBiomarkersImmunoglobulin kappa-ChainsOligoclonal Bands

Identifiers

PMID40694730
PMCPMC12285672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.